First Tracks Biotherapeutics Announces Participation in Upcoming Investor Conferences

Rhea-AI Summary

First Tracks Biotherapeutics (Nasdaq: TRAX) will participate in two upcoming investor conferences. President and CEO Daniel Faga and other executives plan a presentation and one-on-one meetings at the 2026 Jefferies Global Healthcare Conference on June 3, 2026, and one-on-one meetings at the Leerink Partners Therapeutics Forum on July 14, 2026.

A live webcast and 30-day replay of the Jefferies presentation will be available on the company’s investor relations website.

News Market Reaction – TRAX

+2.51%

3 alerts

+2.51% Session close to close

+16.6% Peak Tracked

$631.55M Market Cap

0.1x Rel. Volume

In the May 22 session, TRAX gained 2.51%, reflecting a moderate positive market reaction. Argus tracked a peak move of +16.6% during that session. Our momentum scanner triggered 3 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN DIEGO, Calif., May 21, 2026 (GLOBE NEWSWIRE) -- First Tracks Biotherapeutics, Inc. (Nasdaq: TRAX), a clinical-stage biotechnology company advancing antibody therapeutics that modulate immune pathways implicated in autoimmune and inflammatory diseases, today announced that Daniel Faga, president and chief executive officer, and/or other members of its executive leadership team, are scheduled to participate in multiple upcoming investor conferences:

2026 Jefferies Global Healthcare Conference, New York

• Format – Presentation and one-on-one investor meetings
• Date and Time – Wednesday, June 3, 2026 at 12:15pm ET / 9:15am PT
  
  

Leerink Partners Therapeutics Forum, Boston

• Format – One-on-one investor meetings
• Date and Time – Tuesday, July 14, 2026
  
  

A live webcast of the presentation will be available on the investor section of the First Tracks website at https://ir.firsttracksbio.com/news-events/events. A replay of the webcast will be available for at least 30 days following the event.

About First Tracks Biotherapeutics

First Tracks Biotherapeutics is a clinical stage biotechnology company advancing antibody therapies that modulate immune pathways implicated in autoimmune and inflammatory diseases. Its pipeline includes ANB033, a CD122 antagonist in development for celiac disease and eosinophilic esophagitis; rosnilimab, a pathogenic T cell depleter in development for rheumatoid arthritis; and ANB101, a BDCA2 modulator. To learn more, visit www.FirstTracksBio.com or follow us on LinkedIn.

Investor Contact:
Nick Montemarano
Executive Director, Investor Relations
858.732.0178
investors@firsttracksbio.com

FAQ

When will First Tracks Biotherapeutics (TRAX) present at the 2026 Jefferies Global Healthcare Conference?

First Tracks Biotherapeutics is scheduled to present on Wednesday, June 3, 2026, at 12:15 p.m. ET. According to First Tracks Biotherapeutics, the session will include a formal presentation plus one-on-one investor meetings in New York.

What is the format of First Tracks Biotherapeutics (TRAX) participation at the 2026 Jefferies Global Healthcare Conference?

First Tracks Biotherapeutics plans a presentation and one-on-one investor meetings at the Jefferies Global Healthcare Conference. According to First Tracks Biotherapeutics, the event will be held in New York with the presentation webcast live on the company’s investor relations website.

How can investors access the First Tracks Biotherapeutics (TRAX) webcast for the June 3, 2026 conference?

Investors can access a live webcast of the June 3, 2026 presentation via the First Tracks investor relations website. According to First Tracks Biotherapeutics, a replay will remain available for at least 30 days following the event.

When will First Tracks Biotherapeutics (TRAX) attend the Leerink Partners Therapeutics Forum in 2026?

First Tracks Biotherapeutics is scheduled for one-on-one investor meetings on Tuesday, July 14, 2026, at the Leerink Partners Therapeutics Forum in Boston. According to First Tracks Biotherapeutics, this appearance focuses on direct investor interactions rather than a public presentation.

Who will represent First Tracks Biotherapeutics (TRAX) at the upcoming 2026 investor conferences?

President and CEO Daniel Faga and/or other executive leaders are expected to attend the conferences. According to First Tracks Biotherapeutics, company leadership will participate in the Jefferies Global Healthcare Conference and the Leerink Partners Therapeutics Forum for investor meetings.